Pfizer’s new weight-loss shot: Can one injection a month change obesity treatment as we know it?

With promising mid-stage trial results, berobenatide aims to make obesity treatment more convenient without compromising effectiveness.
Hosted on MSN

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Pfizer said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. The data offer early evidence that the injection can ...

One Injection A Month For Weight Loss? Pfizer's New Obesity Drug Explained

The natural GLP-1 hormone survives in the body for only a few minutes before it is broken down. Drug developers overcome this ...
Mathrubhumi English

EXPLAINED: How does Pfizer's new weight loss drug Berobenatide work?

Obesity has become a growing concern worldwide, and GLP-1 drugs have brought relief to millions struggling with weight ...

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

By Michael Erman NEW YORK, June 6 (Reuters) - Pfizer presented data on Saturday that showed a monthly dose of an experimental ...

Can Pfizer Take Share From Lilly & Novo Nordisk in the Obesity Space?

PFE is betting on monthly obesity treatments and new oral programs to challenge LLY and NVO in a market projected to hit $120 billion by 2035.
CNBC

Pfizer oral weight loss drug may be as effective as Ozempic injection by Novo Nordisk, study says

An oral drug from Pfizer causes a similar amount of weight loss as the blockbuster Ozempic injection, made by rival Novo Nordisk, according to results from a phase two clinical trial. The results were ...